Zalunfiban is a new type of αIIbβ3 antagonist for prehospital treatment of myocardial infarction. Reference standards of Zalunfiban API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Zalunfiban
Catalogue No.:PA 26 0470000
CAS :
Molecular Formula : C16H18N8O2S
Molecular Weight : 386.43
2-Amino-N-(5-(7-(4-nitrosopiperazin-1-yl)-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)pyridin-3-yl)acetamide
Catalogue No.:PA 26 0471000
Molecular Formula : C16H17N9O3S
Molecular Weight : 415.43
2-Amino-N-(2-((5-(7-(4-nitrosopiperazin-1-yl)-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)pyridin-3-yl)amino)-2-oxoethyl)acetamide
Catalogue No.:PA 26 0471001
Molecular Formula : C18H20N10O4S
Molecular Weight : 472.48
2-(5-Aminopyridin-3-yl)-7-(4-nitrosopiperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one
Catalogue No.:PA 26 0471002
Molecular Formula : C14H14N8O2S
Molecular Weight : 358.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
